Exam 4 lecture 7 Flashcards

1
Q

Define lupus

A

Chronic autoimmune disease with diverse clinical presentation.
Immune system attacks healthy tissue and organs throughout the body.
Control of this disease remains a challenge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Predisposing factors to lupus

A

Genetics- 1st degree relatives; 20 x more likely to develop SLE

Hormonal- Estrogen production may modulate the incidence and severity of SLE

Env’t- CIgarette smoking, meds, UV light, air pollution, ciruses, stress, pesticides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is Drug induced lupus erythematosus (DILE)? WHen do symptoms occur? When does resolution occur?

A

Overreaction to certain meds
symptoms occur 3-6 months of drug initiation
Resolution occurs within weeks of drug dx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What us a mnemonic to memorize drugs that cause DILE

A

My Pretty Malar Marking Probably Has A TransIent Quality

Every capital letter is a drug (including the I in transiet)

Methimazole
Propylthiouracil
Methyldopa
Minocycline
Procainamide
Hydralazine
Anti-TNF agents (infliximab and etanercept)
Terbinafine
Isoniazid
Quinidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

s/s of lupus (SLE)

A

Fatigue
Depression
Photosensitivity
Joint pain
N/V
Fever
Weight loss
Malar “butterfly” Rash

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some mucocutaneous s/s of SLE?
Opthalmologic?
Renal?

A

mucocutaneous- butterfly rash, discoid rash, raynaud phenomenon

Opthalmologic- Lupus retinopathy

Renal- Lupus nephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is Raynaud Phenomenon

A

Exaggerated vascular response to cold temperature or emotional stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the two diagnostic tools that will be used for lupus

A

SLICC
EULAR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does SLICC criteria work

A

Must meet > 4 total features with 1 from each group

OR

Biopsy proven lupus nephritis WITH systemic lupus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

criteria for EULAR

A

Patients score is > or = 10 AND atleast 1 clinical criterion is fulfilled

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some key labs for SLE? WHat is a normal range? WHat is its specificity?

A
  1. Anti-nuclear antibody (ANA)- reference range (<1:40)= negative. Positive in lupus patients but not specific
  2. Anti double stranded DNA (Anti-dsDNA)- Negative, High specificity (correlates with disease activity and is an important marker in lupus nephritis)
  3. anti- smith antibody (Anti-SM)- negative- High specificity for diagnosis
  4. Antiphospholipid antibody- negative, increases clotting factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are 5 drug classes that patients will be on when they have lupus?

A

Hydroxychloriquin (HCQ)
NSAIDs
Glucocorticoids
Immunosuppressnats (IS)
Biologics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MOA of HCQ? Place in therapy? Benefit of HCQ? Dosing (exam)

A

MOA- anti malaria-> inhibit overactive immune cells

Place in therapy- Recommended for ALL pts with SLE

Benefits- reduces flares and help manage pain

Dosing- 200-400mg PO daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Side effects of HCQ

A

-opthalmic: retinal toxicity (bulls eye maculopathy)
-Hemolytic anemia if you have G6PD deficiency
- CNS (depression, anxiety)
- CV- QT prolongation
- HS rxn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What type of disorder is G6PD deficiency

A

X-linked disorder that causes RBCs to prematurely break down (happens more in males)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What drug do we not give if patient has G6PD deficiency

A

HCQ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Monitoring parameters for HCQ

A

CBC
LFTs
SCr
EKG

Periodic eye exam 3 onths after eye exams and annually there after

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

MOA of NSAIDs? Benefits? Place in therapy?

A

MOA- inhibits COX 1 and 2 to decrease the formation of prostaglandin precursor

Benefits- Antipyretic, anti-inflammatory and analgesic

Place in therapy- 1st line for mild symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Dosing of Ibuprofen and naproxen

A

Ibuprofen- 400-600 mg PO Q 6-8 H
Naproxen- 500 mg PO BID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Side effects of NSAIDs

A

GI bleeding, gastritis or perforation
CV- increased BP,worsening HF, CV events
Renal- increased Scr, renal toxicity
Hepatic- Hepatotoxicity

21
Q

Monitoring parameters for NSAIDs

A

CBC
LFTs
SCr
BP
S/sx of fluid retention and bleeding

22
Q

Glucocorticoid MOA? Benefits? Place in therapy?

A

MOA: Inhibits B and T cell responses
Benefits: Anti inflammatory and helpful during flares
Place- adjunct treatment if not responsive to NSAIDs, HCQ

23
Q

Dosing of oral glucocorticoid (prednisone)

A

MIld-moderate disease: Prednisone 5-20 mg/day
Severe: 1 mg/kg/day

24
Q

IV dosing of glucocorticoid

A

Methylprednisolone: 500-1000 mg IV x 3-6 days then PO prednisone

25
For topical glucocorticoids, name low potency, moderate potency and high potency glucocorticoids and where they are used
low potency: Flucinolone and hydrocortisone butyrte (face) Moderate: Triamcinalone and Betamethasone (Trunk and extremities) High potency: CLobetasol (scalp sores and palms)
26
PO/IV glucocorticoids side effects
Opthalmic: glaucoma CV: increased BP Bone: Increased risk of osteoporosis GI: GI bleed CNS: Psychosis/sleep disturbances Cushings syndrome weight gain
27
Topical glucocorticoids side effets
Skin atrophy, rosacea, telengiectasis
28
Monitoring for glucocorticoids
Baseline: BP, BMP, FLP, BMD ROutine BMP q 6 mo FLP 6 mo BMD: annually
29
Immunosuppressants MOA? Place in therapy? Meds?
MOA- suppression of immune system from attacking healthy cells Place in therapy: Adjunct to steroid therapy to lower the dose or insufficient response to HCQ meds: Methotrexate Mycophenolate cyclophosphamide azathroprine
30
Methotrexate dosing? side effects? Mycophenolate dosing? Side effects?
Methotrexate: 5-15 mg once weekly. May cuse BMS, infection Mycophenolate: 1-1.5 g BID, BMS, infection, malignancy, AIS
31
Cyclophosphamide dosing and side effects? Azathioprine Dosing and side effects?
Cyclophosphamide: 1 - 1.5 mg/kg once daily IV: 0.5 mg/m2 BSA q month c=x 6 months side effects: BMS, infection, malignancy Azathioprine: 50 mg daily BMS, infection, malignancy Monitor for TPMT deficiency in azathioprine BMS= bone marrow suppression
32
Biologics MOA? Place in therapy? Medications?
MOA: Monoclonal antibodies that block B cell mediated immunity Place in therapy: - inadequate response to antimalarial and immunosuppressants - severe disease Medication -Belimumab - rituxiamb - anifrolumab
33
Pearls with biologics with lupusq
No live vaccines 30 days before starting therapy OR during therapy Do not use more than 1 biologic at the same time
34
Belimumab dosing? Side effects?
10 mg/kg every 2 weeks x 3 doses HS and infusion rxn
35
Anifrolumab dosing and side effects
300 mg every 4 wks, HS rxn
36
Rituximab dosing? Side effects?
1g on days 0 and 15 or 375 mg.m2 once weekly for 4 doses Side effects- Infusion rxn, Hep B reactivation, ML premedicate 30 mins prior to administration
37
What is an additional biologic that can be used in lupus
Calcineurin inhibitors (CNI) - tacrolimus - vocolosporin (oral lupus med)
38
non pharm adjustments for lupus
Balance of rest and exercise Smoking cessation Limit sun exposure and use fo sun screen
39
How common and dangerous is cutaneous lupus? First line treatmemnt? Refractory treatment?
10% of lupus cses, rarely life threatening. Presents with rash and lesions 1st line: 1)TOpica; agents - GC: clobetasol, betamethasone, hydrocortisone,triamcinalone CNI: Tacrolimus, pimecrolimus 2)HCQ 3) systemic GC Refractory - high dose GC MTX MMF (mycophenolate)
40
how common and dangerous is lupus nephritis? Therapy for class I/II lupus nephritis?
LN is a serious complication of SLE which can affect 6-% of patients within 10 yrs of diagnosis Therapy Mild/moderate nephritis - GC+/- another immunosuppressive AZA, MMF or CNI Severe nephritis MMF (preferred) or CYC +/- GC Triple therapy: - belimumab + MMF or CYC +/- GC CNI + MMF +/- GC
41
Therapy for class III or IV lupus nephritis
-Glucocorticoid + -CNI + MPAA or -MPAA (Most preferred) (can have induction and maintenance) or - cyclophosphamide (2nd line after MPAA) or -Belimumab + MPAA or reduced dose cyclophosphamide
42
Drugs for FLuid retention Pain and inflammation?
Diuretic NSAIDs (recommend tylenol first)
43
Compare healthy pregnancy vs lupus pregnancy? When is the best prognosis COntraception?
Lupus pregnancies at more risk for - miscarriages - fetal growth retardation etc Best prognosis is when the patient achieves remission for > 6 months COntraception - Avoid estrogen containing contraception - Screen for antiphosholipif syndrome
44
Which drugs are safe to use in pregancy? Which should we discontinue
HCQ ( safe throughout pregnancy) NSAIDs ( discontinue at 20 weeks or later) GC- safe throughout MMF, CYC, MTX- contraindicated AZA- risk vs benefit with proveider Biologics- do not recommend
45
What is antiphospholipid syndorme
An auto immune disorder characterized by antiphospholipid syndrome that can cause blood clots and miscarriages
46
Prophylaxis for antiphospholipid antibody
- no prior fetral loss- apsirin 81 mg - Recurrent fetal loss- aspirin 81 mg + LMWH If acute thrombotic event/hx of thrombosis- LMWH
47
Can we use warfarin in pregnant woman
NEVER
48